AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04117165 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patient Current Care
Description: The rheumatologist will use the french guidelines of rheumatoid arthritis to choose the more adapted biotherapy treatment to the patient.
Study NCT06093997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage treatment
Description: The patient sits upright and the neck naturally relaxes. The doctor uses techniques such as pressing and kneading to relax the soft tissues of the neck, and massages points such as FengMen, FengChi, JingJiaji, JianJing,Tianzong and so on. The focus is on using muscle relaxation techniques around the soft tissues of spasms and pain areas to relax the patient's neck and shoulders. All procedures were performed from mild to severe, once a week for 15 minutes each time, for a total of 4 weeks of treatment.
Study NCT06093997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cupping
Description: Use a 4-5cm diameter suction cupping for cupping. The treatment area is coated with glycerol, and the cupping is aspirated and adsorbed on the skin. The cupping is slowly pushed along the patient's neck, along the urinary bladder channel of Foot-Taiyang and governor's meridians from top to bottom, repeating back and forth 9 times. Once a week, for a total of 4 weeks of treatment.
Study NCT06093997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bloodletting
Description: the doctor takes JianZhongShu, one on the left and one on the right, with a total of 2 acupoints. After disinfecting with 75% alcohol cotton balls, the patient is quickly pricked 5 times with a blood collection needle, and cupping is performed at the needle hole. After 5 minutes, remove the jar, wipe the blood clean, and disinfect the needle hole. Once a week, for a total of 4 weeks of treatment.
Study NCT06547190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High AGEs diet
Description: Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The High AGEs diet was cooked for example by baking and grilling.
Study NCT06547190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low AGEs diet
Description: Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The low AGEs diet was cooked for example by steaming and boiling.
Study NCT05529511 — intervention group
Intervention type: OTHER
Intervention: Phase 1 - semi-structured interviews
Description: Semi-structured face-to-face or virtual interviews.
Study NCT05529511 — intervention group
Intervention type: OTHER
Intervention: Phase 2 - consensus meeting
Description: Face-to-face or virtual meeting(s)
Study NCT04878146 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sacro-spinous fixation
Description: Uterine cervix will be attached to the sacro-spinous ligament
Study NCT04878146 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subtotal hysterectomy
Description: Done on both arms
Study NCT04878146 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Subtotal hysterectomy
Description: Done on both arms
Study NCT04878146 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sacrocolpopexy
Description: Uterine cervix is attached to sacral promontory with two synthetic meshes
Study NCT05380635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hypericin
Description: HyBryte is synthetic hypericin formulated as a 0.25% hypericin ointment.
Study NCT03682042 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Umbilical Cord Milking
Description: At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.
Study NCT06484218 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional endodontic treatment
Description: The conventional access cavity was prepared under the microscope through the incisal edge as this approach facilitates straight-line access. A high-speed contra-angle handpiece, associated with a long surgical bur 010 (Meisinger, CO, USA), was used until the dentin was exposed, which is in general 3 to 4 millimeters from the incisal edge. Then, the ultrasonic tip ED5 (woodpecker-DTE, Guilin, China) was marked with a stopper according to the calcification level viewed on the preoperative CBCT and then used gently at the stopper level until the canal was found.
Study NCT06484218 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional endodontic treatment
Description: The conventional access cavity was prepared under the microscope through the incisal edge as this approach facilitates straight-line access. A high-speed contra-angle handpiece, associated with a long surgical bur 010 (Meisinger, CO, USA), was used until the dentin was exposed, which is in general 3 to 4 millimeters from the incisal edge. Then, the ultrasonic tip ED5 (woodpecker-DTE, Guilin, China) was marked with a stopper according to the calcification level viewed on the preoperative CBCT and then used gently at the stopper level until the canal was found.
Study NCT06484218 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guided endodontic treatment
Description: In all cases, digital and clinical protocols were followed according to the method reported by Zehnder et al. and Connert et al. The guide was replaced, and the access cavity precisely drilled using the EG6 drill, mounted on a low-speed contra-angle handpiece. With every 3 mm of progression, the cavity was rinsed, and the head of the bur was cleaned until reaching the canal. The irrigation was done to avoid overheating the dentine and the accumulation of dentine debris
Study NCT06484218 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Guided endodontic treatment
Description: In all cases, digital and clinical protocols were followed according to the method reported by Zehnder et al. and Connert et al. The guide was replaced, and the access cavity precisely drilled using the EG6 drill, mounted on a low-speed contra-angle handpiece. With every 3 mm of progression, the cavity was rinsed, and the head of the bur was cleaned until reaching the canal. The irrigation was done to avoid overheating the dentine and the accumulation of dentine debris
Study NCT06256536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GZR18
Description: 0.6 mg-30 mg
Study NCT06256536 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: administered the same volume as GZR18
Study NCT06009913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: online teaching
Description: teaching of subject was done using online system only
Study NCT06009913 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: In class teaching
Description: subjects were explained in normal class room
Study NCT05434481 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mitochondrial dynamic analysis in the aorta samples and metabolomic profiling in the aortic diseases
Description: * For each patient: a segment of aorta will be sampled and cutted into 4 parts~  * 1 fragment placed in a Falcon tube containing DMEM (Dulbecco's Modified Eagle Medium, Thermo Fisher®), temporarily stored at + 4°C, for primary culture of smooth muscle cells will allow analysis of the mitochondrial network.~ * 1 fragment placed in a Falcon tube containing Allprotect Tissue Reagent (QIAGEN®), stored at -80°C for gene (RT-PCR) and protein (Western Blot) analysis.~ * 2 fragments each placed in dry cryotube stored at - 80°C will be used for metabolomic analysis.~* For each patient, 2 arterial blood samples will be collected before general anaesthesia~  * One tube of whole blood stored at -80°C for metabolomic analysis.~ * One tube of blood stored at -80°C for plasma cytokines
Study NCT05434481 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Mitochondrial dynamic analysis in the aorta samples and metabolomic profiling in the aortic diseases
Description: * For each patient: a segment of aorta will be sampled and cutted into 4 parts~  * 1 fragment placed in a Falcon tube containing DMEM (Dulbecco's Modified Eagle Medium, Thermo Fisher®), temporarily stored at + 4°C, for primary culture of smooth muscle cells will allow analysis of the mitochondrial network.~ * 1 fragment placed in a Falcon tube containing Allprotect Tissue Reagent (QIAGEN®), stored at -80°C for gene (RT-PCR) and protein (Western Blot) analysis.~ * 2 fragments each placed in dry cryotube stored at - 80°C will be used for metabolomic analysis.~* For each patient, 2 arterial blood samples will be collected before general anaesthesia~  * One tube of whole blood stored at -80°C for metabolomic analysis.~ * One tube of blood stored at -80°C for plasma cytokines
Study NCT04002388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: activity monitor group
Description: will receive a FitBit and will be asked to wear this for one year
Study NCT04002388 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: usual care group
Description: will NOT receive a FitBit
Study NCT06062771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FIDIAL PLUS
Description: 1.8% solution of sodium hyaluronate that is derived from a bacterial fermentation (not of animal origin).
Study NCT06062771 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: IAL®-F
Description: Animal derived 1.8% sodium hyaluronate equivalent to FIDIAL PLUS
Study NCT04719000 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhFSH+rhLH
Description: 300 IU of rhFSH and 150 IU of rhLH (Pergoveris®) GnRH antagonist: cetrorelix 0.25 mg (Cetrotide® - Merck) GnRH antagonist: cetrorelix 0.25 mg (Cetrotide® - Merck) Recombinant human chorionic gonadotropin (rhCG) 6500 IU (Ovitrelle® - Merck) micronized progesterone 90 mg (Crinone 8% ® - Merck)
Study NCT04719000 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rhFSH
Description: 300 IU rhFSH (Gonal-F®- Merck) GnRH antagonist: cetrorelix 0.25 mg (Cetrotide® - Merck) GnRH antagonist: cetrorelix 0.25 mg (Cetrotide® - Merck) rhCG 6500 IU (Ovitrelle® - Merck) micronized progesterone 90 mg (Crinone 8% ® - Merck)
Study NCT05366764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR443765
Description: solution for injection
Study NCT05366764 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: solution for injection
Study NCT05366764 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Salbutamol or levosalbutamol
Description: metered dose inhaler
Study NCT05366764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salbutamol or levosalbutamol
Description: metered dose inhaler
Study NCT06486246 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adductor canal block
Description: Injection of the local anesthetic prior to the surgery, either in the the adductor canal or in the genicular nerves by the anesthesiologist under ultrasound guidance.
Study NCT05473052 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preoperative home-based exercise training
Description: 1) Home-based aerobic and resistance exercise training (preoperative period)~Dose of aerobic exercise:~1. Type: Walking~2. Frequency: 3 sessions per week~3. Duration: 30 minutes~4. Intensity: Rate of perceived exertion on Borg Category Ratio-10 (3-5)~5. Progression: Increase the walking duration in 10 minutes (after week 2)~Dose of resistance exercise:~1. Type: Six exercises for upper and lower limbs using bodyweight and free-wights of 1-2kg~2. Frequency: 2 sessions per week~3. Duration: 2 sets x 15 repetitions~4. Rest in-between sets: 45 seconds~5. Intensity:Rate of perceived exertion on Borg Category Ratio-10 (3-5)~6. Progression: Increase the number of sets (3 sets of 15 repetitions after week~2) Weekly telephone supervision: A physical therapist carried out weekly telephone calls with all participants to monitor adverse events, give positive reinforcement and recommend strategies to overcome barriers that arise during the exercise program.
Study NCT05817916 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ESP block
Description: ESP block: ultrasound guided erector spina plane block
Study NCT05817916 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LP block
Description: LP block: ultrasound guided lumbar plexus block
Study NCT05883410 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: It is important for the therapist to organize a home exercise program to provide edema and pain control. The exercise program should be specific and clear to the patient. The exercise program will be taught to the patient and given as a home program
Study NCT05883410 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: It is important for the therapist to organize a home exercise program to provide edema and pain control. The exercise program should be specific and clear to the patient. The exercise program will be taught to the patient and given as a home program
Study NCT05883410 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF Technique
Description: While the limb is in the agonist pattern, the patient is instructed to perform isometric contractions for 5-8 seconds against maximum resistance without movement at the limiting point. After maximum isometric contraction, the patient is instructed to actively relax.Participants in the second group will be applied 10 repetitions of isometric contractions for 8 seconds at the limitation points of the movement with the PNF techniques, the hold and relax active movement technique in the direction of wrist flexion and extension.
Study NCT05883410 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mulligan Mobilization
Description: In thw Mobilization with movement technique; the patient is expected to perform painless ROM. After obtaining painless movement in the patients participating in the study, this application will be applied to the patient with the painless active movement technique in 10 repetitions and 2-3 sets. Rest time between sets will be 15-20 seconds. Patients will be taught self-mobilization to ensure the continuity of painless movement. Self-mobilization will be applied by the patient at home with 10 repetitions every two hours (29).
Study NCT06158269 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DVRd
Description: The patients will receive 4 cycles of DVRd induction therapy. After achieving PR or better response, they will receive stem cell mobilization, collection and the following ASCT. Then, the patients will accept 4 cycles of DVRd consolidation and DVR maintenance therapy. Once they sustain MRD negative condition for at least 12 months, the patients will enter the maintenance stage of lenalidomide monotherapy. Otherwise, the triple drug maintenance therapy will be continued for a total of 24 cycles or until disease progression, death, intolerance, withdrawal due to other reasons, or termination/end of the study.
Study NCT06243211 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: DMED
Description: Decompression of spinal cord with stabilization - posterior approach.
Study NCT06243211 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ANGI
Description: Implantation of nerve tissue following decompression ans stabilization.
Study NCT04870190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Almonertinib
Description: Almonertinib will be administered orally at a dose of 165 mg per time, Q.D.
Study NCT04870190 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Osimertinib
Description: Osimertinib will be administered orally at a dose of 80 mg per time, Q.D.
Study NCT05617703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glass Ionomer with Advanced Glass Hybrid Technology (Equia forte HT fil, GC, Japan)
Description: Advanced Glass Hybrid technology (AGH) was achieved through introduction of ultra-fine highly reactive glass and high-molecular weight polyacrylic acid powders within conventional glass using particles and fillers with close refractive indexes
Study NCT05617703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glass Ionomer with Advanced Glass Hybrid Technology (Equia forte HT fil, GC, Japan)
Description: Advanced Glass Hybrid technology (AGH) was achieved through introduction of ultra-fine highly reactive glass and high-molecular weight polyacrylic acid powders within conventional glass using particles and fillers with close refractive indexes
Study NCT05151406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: educational program
Description: The needed knowledge about hematopoietic stem cell transplantation in a trial to correct their myths and misconceptions about this type of treatment. The educational pamphlet included three theoretical parts: bone marrow transplantation, bone marrow donation, and stem cells banking
Study NCT06217172 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: RHEUPP App
Description: RHEUPP App; Monthly RAPID3 response; General recommendations for managing Flare through App and Social Monitor for appropriate orientation; 3 month consultation by telehealth.
Study NCT06217172 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Follow-up
Description: Usual Care in Rheumatoid Arthritis Ambulatory Service
Study NCT06080061 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionated accelerated radiation therapy
Description: Hypofractionated accelerated radiation therapy
Study NCT06093425 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
Description: All medications administered intravenously
Study NCT06093425 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
Description: All medications administered intravenously
Study NCT06286969 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: The needles are inserted into the subject in a certain way to stimulate specific parts of the body to treat the disease.
Study NCT03938922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Active Investigational Treatment ENT-01
Description: ENT-01 will be administered in tablet form, once daily.~Other Names:~ENT-01
Study NCT05733247 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Copenhagen adductor exercise
Description: Week 1 - 1 session per week consisting of 2 sets of 5 reps of the exercise Week 2 - 2 sessions per week consisting of 2 sets of 6 reps of the exercise Week 3 -3 sessions per week consisting of 3 sets of 6 reps of the exercise Week 4 - 3 sessions per week consisting of 3 sets of 8 reps of the exercise Weeks 5 and 6 - 3 sessions per week consisting of 3 sets of the exercise.
Study NCT05733247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The adduction and abduction partner exercise
Description: Week 1 - 1 session per week consisting of 2 sets of 5 reps of the exercise Week 2 - 2 sessions per week consisting of 2 sets of 6 reps of the exercise Week 3 -3 sessions per week consisting of 3 sets of 6 reps of the exercise Week 4 - 3 sessions per week consisting of 3 sets of 8 reps of the exercise Weeks 5 and 6 - 3 sessions per week consisting of 3 sets of the exercise.
Study NCT04884893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous Oxide
Description: 50% nitrous oxide
Study NCT05832463 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Carbohydrate blocking supplement (CBS)
Description: The CBS is composed of a Hypromellose outer shell, and filled with mulberry leaf extract, berberine HCl, cinnamon bark powder, and cinnamon bark essential oil.~Mulberry leaf extract (Reducose) - 250 mg Berberine HCl (97%)(Berberis aristata root extract)- 25 mg Organic cinnamon powder (Cinnamon (Cinnamomum loureirii) bark powder) - 20 mg Essential oil blend (Grapefruit (Citrus paradisii) peel oil, Lemon (Citrus limon) peel oil Peppermint (Mentha piperita) aerial (leaf/stem) oil), Ginger (Zingiber officinale) root oil, Cinnamon (Cinnamomum zeylanicum) bark oil) - 5 mg
Study NCT05832463 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: The placebo is composed of a Hypromellose outer shell filled with extra virgin olive oil.
Study NCT05997056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab-sirolimus
Description: Prospective phase 2 single arm, open-label, multi-institutional study to determine the efficacy and safety prospective of nab-sirolimus administered by IV infusion
Study NCT05608161 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: speech in noise test
Description: The noise masker was a stream of steady-state speech-spectrum noise, whose spectrum was representative of the average spectrum of target sentences. The speech masker was a 47-s loop of digitally combined continuous recordings for Chinese nonsense sentences. Patients from the idiopathic sudden sensorineural hearing loss (ISSNHL) group and control group were tested bilateral (left, right) speech-in-noise (SIN) perception of various signal-to-noise ratios (SNRs) under speech and noise masking conditions. Each participant has to complete four consequent levels of SNRs (-12, -8, -4, 0 decibel (dB) for most of control group, -8, -4, 0, 4 dB for ISSNHL group). In addition, the benefits of spatial separation cues under these two types of masking were analyzed.